Affinity modulation of the platelet integrin α(11b)β3 by α- chymotrypsin: A possible role for Na+/Ca2+ exchanger

Blood

Volumn 88, Issue 7, 1996, Pages 2594-2602

  Shiraga, Masamichi ^b   Tomiyama, Yoshiaki ^a   Honda, Shigenori ^b   Kashiwagi, Hirokazu ^b   Kosugi, Satoru ^b   Handa, Makoto ^b   Ikeda, Yasuo ^b   Kanakura, Yuzuru ^b   Kurata, Yoshiyuki ^b   Matsuzawa, Yuji ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN A; INTEGRIN;

ARTICLE; BINDING AFFINITY; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 10144241696     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2594.bloodjournal8872594     Document Type: Article

References (51)

1. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
2. Ruoslahti E: Integrins. J Clin Invest 87:1, 1991
3. Faull RJ, Ginsberg MH: Dynamic regulation of integrins. Stem Cells 13:38, 1995
4. Loscalzo J: The relation between atherosclerosis and thrombosis. Circulation 86:111-95, 1992
5. Ware JA, Heistad DD: Platelet-endothelium interactions. N Engl J Med 328:628, 1993
6. van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HFG, Connolly TM, de Groot PG, Sixma JJ: Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest 93:615, 1994
7. Phillips DR, Charo IF, Parise LV, Fitzgerald LA: The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831, 1988
8. 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 267:11300, 1992
9. Bennett JS, Vilaire G: Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 64:1393, 1979
10. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL: Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 69:625, 1987
11. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234, 1991
12. Shattil SJ, Hoxie JA, Cunningham M, Brass LP: Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 260:11107, 1985
13. Tomiyama Y, Tsubakio T, Piotrowicz RS, Kurata Y, Loftus JC, Kunicki TJ: The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood 79:2303, 1992
14. 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul 1:883, 1990
15. Kroll MH, Schafer AI: Biochemical mechanisms of platelet activation. Blood 74:1181, 1989
16. 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem 266:17106, 1991
17. Gulino D, Ryckewaert JJ, Andrieux A, Rabiet MJ, Marguerie G: Identification of a monoclonal antibody against platelet GPIIb that interacts with a calcium-binding site and induces aggregation. J Biol Chem 265:9575, 1990
18. 3 subunit. J Biol Chem 270:11947, 1995
19. 3 (platelet GPIIb-IIIa). Cell 65:409, 1991
20. Greenberg JP, Packham MA, Guccione MA, Harfenist EJ, Orr JL, Kinlough-Rathbone RL, Perry DW, Mustard LF: The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood 54:753, 1979
21. Niewiarowski S, Budzynski AZ, Morinelli TA, Brudzynski TM, Stewart GJ: Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem 256:917, 1981
22. Kornecki E, Tuszynski GP, Niewiarowski S: Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa. J Biol Chem 258:9349, 1983
23. Peerschke EIB, Coller BS: A murine monoclonal antibody that blocks fibrinogen binding to normal platelets also inhibits fibrinogen interactions with chymotrypsin-treated platelets. Blood 64:59, 1984
24. Niewiarowski S, Norton KJ, Eckardt A, Lukasiewicz H, Holt JC, Kornecki E: Structural and functional characterization of major platelet membrane components derived by limited proteolysis of glycoprotein IIIa. Biochim Biophys Acta 983:91, 1989
25. Pidard D, Frelinger AL, Bouillot C, Nurden AT: Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolylic cleavage at the carboxyterminus of the membrane glycoprotein lib heavy chain. Eur J Biochem 200:437, 1991
26. D'Souza SE, Ginsberg MH, Burke TA, Lam SCT, Plow EF: Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 242:91, 1988
27. Beer J, Coller BS: Evidence that platelet glycoprotein IIIa has a large disulfide-bonded loop that is susceptible to proteolytic cleavage. J Biol Chem 264:17564, 1989
28. Calvete JJ, Henschen A, Gotizalez-Rodriguez J: Assignment of disulfide bonds in human platelet GPIIIa. A disulfide pattern for the β-subunits of the integrin family. Biochem J 274:63, 1991
29. Tokuhira M, Handa M, Kamata T, Ishiwata N, Yokoyama K, Murata M, Kawai Y, Watanabe K, Katayama M, Ikeda Y: A conformation dependent anti-platelet GPIIb-IIIa complex monoclonal antibody that alters the receptor into its active form. Thromb Haemost 69:920, 1993 (abstr)
30. Pidard D, Montgomery RR, Bennett JS, Kunicki TJ: Interaction of AP2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem 258:12582, 1983
31. Tomiyama Y, Kunicki TJ, Zipf TF. Ford SB, Aster RH: Response of human platelets to activating monoclonal antibodies: Importance of FcγRII (CD32) phenotype and level of expression. Blood 80:2261, 1992
32. 2+ homeostasis in unstimulated platelets. J Biol Chem 259:12571, 1984
33. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim Biophys Acta 988:73, 1989
34. Lefkovits J, Plow EF, Topol EJ: Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 332:1553, 1995
35. 2+ exchange in membrane vesicle and papillary muscle preparations from guinea pig heart by analogs of amiloride. Proc Natl Acad Sci USA 81:3238, 1984
36. Garcia ML, Slaughter RS, King VF, Kaczorowski GJ: Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil. Biochemistry 27:2410, 1988
37. 2+ exchange. Eur J Pharmacol 105:317, 1984
38. 2+ transport in nerve fibers. Biochim Biophys Acta 947:549, 1988
39. 2+ exchange in plasma membrane vesicles. Thromb Haemost 57:337, 1987
40. 2+ exchanger of the human platelet. J Membrane Biol 130:63, 1992
41. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH: Integrin cytoplasmic domains mediate inside-out signal transduction. J Biol Chem 124:1047, 1994
42. 2+ exchange in human neutrophils. Am J Physiol 254:C150, 1988
43. 2+ exchange in the generation of Superoxide radicals by human neutrophils. J Biol Chem 265:13449, 1990
44. 2+ required for T cell activation. J Immunol 149:1912, 1992
45. Siffert W, Gengenbach S, Scheid P: Inhibition of platelet aggregation by amiloride. Thromb Res 44:235, 1986
46. Home WC, Simons ER: Effects of amiloride on the response of human platelets to bovine αthrombin. Thromb Res 13:599, 1978
47. 2+ exchanger. Science 250:562, 1990
48. Reilander H, Achilles A, Friedel U, Maul G, Lottspeich F, Cook NJ: Primary structure and functional expression of the Na/Ca,K-exchanger from bovine rod photoreceptors. EMBO J 11:1689, 1992
49. 2+ exchange in giant excised sarcolemmal membrane patches. Nature 344:242, 1990
50. Espinosa-Tanguma R, DeSantiago J, Rasgado-Flores H: α-Chymotrypsin deregulation of the sodium-calcium exchanger in barnacle muscle cells. Am J Physiol 265:C1118, 1993
51. 3) in isolated platelet membranes. Biochem J 292:749, 1993